Evoke Pharma Inc reports

Location
420 Stevens Avenue, Suite 230, Solana Beach, CA
State of incorporation
Delaware
Fiscal year end
December 31
Data updated at
9/10/2024, 01:26 AM
Form type Sec Links Description Filing date Reporting date
8-K Report | Data 8-K Aug 16, 2024 Aug 15, 2024
8-K Report | Data 8-K Aug 13, 2024 Aug 13, 2024
10-Q Report | Data 10-Q Aug 13, 2024 Jun 30, 2024
8-K Report | Data 8-K Aug 1, 2024 Jul 31, 2024
8-K Report | Data 8-K Jun 20, 2024 Jun 20, 2024
8-K Report | Data 8-K Jun 7, 2024 Jun 4, 2024
8-K Report | Data 8-K May 28, 2024 May 22, 2024
10-Q Report | Data 10-Q May 14, 2024 Mar 31, 2024
8-K Report | Data 8-K May 14, 2024 May 14, 2024
10-K/A Report | Data 10-K/A May 14, 2024 Dec 31, 2023
8-K Report | Data 8-K May 14, 2024 May 13, 2024
8-K Report | Data 8-K Mar 25, 2024 Mar 25, 2024
8-K Report | Data 8-K Mar 21, 2024 Mar 20, 2024
8-K Report | Data 8-K Mar 18, 2024 Mar 18, 2024
10-K Report | Data 10-K Mar 14, 2024 Dec 31, 2023
8-K Report | Data 8-K Mar 14, 2024 Mar 14, 2024
SC 13G Report Mar 13, 2024
SC 13G Report EVOK13G Mar 11, 2024
8-K Report 8-K Feb 23, 2024 Feb 21, 2024
SC 13G Report SCHEDULE FILED TO REPORT ACQUISITION OF BENEFICIAL OWNERSHIP Feb 20, 2024
8-K Report 8-K Feb 14, 2024 Feb 13, 2024
SC 13G Report Feb 13, 2024
8-K Report | Data 8-K Feb 9, 2024 Feb 8, 2024
8-K Report | Data 8-K Nov 29, 2023 Nov 27, 2023
8-K Report | Data 8-K Nov 27, 2023 Nov 27, 2023
8-K Report | Data 8-K Nov 22, 2023 Nov 21, 2023
10-Q Report | Data 10-Q Nov 9, 2023 Sep 30, 2023
8-K Report | Data 8-K Nov 9, 2023 Nov 9, 2023
8-K Report | Data 8-K Nov 1, 2023 Oct 31, 2023
8-K Report | Data 8-K Oct 12, 2023 Oct 9, 2023
8-K Report | Data 8-K Aug 10, 2023 Aug 10, 2023
10-Q Report | Data 10-Q Aug 10, 2023 Jun 30, 2023
8-K Report | Data 8-K Jul 21, 2023 Jul 19, 2023
8-K Report | Data 8-K May 26, 2023 May 24, 2023
8-K Report | Data 8-K May 15, 2023 May 15, 2023
10-Q Report | Data 10-Q May 15, 2023 Mar 31, 2023
8-K Report | Data 8-K May 11, 2023 May 10, 2023
8-K Report | Data 8-K May 9, 2023 May 9, 2023
8-K Report | Data 8-K May 1, 2023 May 1, 2023
8-K Report | Data 8-K Apr 20, 2023 Apr 20, 2023
8-K Report | Data 8-K Apr 6, 2023 Apr 6, 2023
8-K Report | Data 8-K Mar 23, 2023 Mar 23, 2023
10-K Report | Data 10-K Mar 21, 2023 Dec 31, 2022
8-K Report | Data 8-K Mar 21, 2023 Mar 21, 2023
8-K Report | Data 8-K Feb 21, 2023 Feb 21, 2023
8-K Report | Data 8-K Feb 13, 2023 Feb 8, 2023
8-K Report | Data 8-K Jan 30, 2023 Jan 30, 2023
8-K Report | Data 8-K Nov 30, 2022 Nov 30, 2022
10-Q Report | Data 10-Q Nov 9, 2022 Sep 30, 2022
8-K Report | Data 8-K Nov 9, 2022 Nov 9, 2022
8-K Report | Data 8-K Sep 20, 2022 Sep 20, 2022
8-K Report | Data 8-K Aug 26, 2022 Aug 24, 2022
8-K Report | Data 8-K Aug 10, 2022 Aug 10, 2022
10-Q Report | Data 10-Q Aug 10, 2022 Jun 30, 2022
8-K Report | Data 8-K Jun 8, 2022 Jun 7, 2022
8-K Report | Data 8-K May 23, 2022 May 23, 2022
8-K Report | Data 8-K May 20, 2022 May 19, 2022
8-K Report | Data 8-K Q1 EARNINGS RELEASE May 10, 2022 May 10, 2022
10-Q Report | Data 10-Q May 10, 2022 Mar 31, 2022
8-K Report | Data 8-K Apr 28, 2022 Apr 27, 2022
8-K Report | Data 8-K Apr 26, 2022 Apr 26, 2022
10-K Report | Data 10-K Mar 8, 2022 Dec 31, 2021
8-K Report | Data 8-K Mar 8, 2022 Mar 8, 2022
8-K Report | Data 8-K Feb 24, 2022 Feb 24, 2022
8-K Report | Data 8-K Feb 17, 2022 Feb 17, 2022
8-K Report | Data 8-K 02.01.22 Feb 2, 2022 Feb 1, 2022
8-K Report | Data 8-K Jan 4, 2022 Jan 4, 2022
8-K Report | Data 8-K Dec 30, 2021 Dec 29, 2021
10-Q Report | Data 10-Q Nov 10, 2021 Sep 30, 2021
8-K Report | Data 8-K Nov 10, 2021 Sep 30, 2021
8-K Report | Data 8-K Oct 20, 2021 Oct 20, 2021
8-K Report | Data 8-K Sep 29, 2021 Sep 29, 2021
10-Q Report | Data 10-Q Aug 12, 2021 Jun 30, 2021
8-K Report 8-K Aug 12, 2021 Aug 12, 2021
8-K Report 8-K Aug 2, 2021 Aug 2, 2021
8-K Report 8-K Jul 14, 2021 Jul 14, 2021
8-K Report 8-K Jun 29, 2021 Jun 29, 2021
8-K Report 8-K Jun 15, 2021 Jun 15, 2021
8-K Report 8-K - PATENT-ORANGE BOOK APPROVAL Jun 8, 2021 Jun 8, 2021
8-K Report 8-K - PATENT-ORANGE BOOK Jun 2, 2021 Jun 2, 2021
8-K Report 8-K - REED APPOINTMENT May 14, 2021 May 13, 2021
8-K Report 8-K - Q12021 May 12, 2021 May 12, 2021
10-Q Report | Data 10-Q May 12, 2021 Mar 31, 2021
SC 13G Report ACQUISITION OF BENEFICIAL OWNERSHIP May 6, 2021
8-K Report 8-K - 2021 ANNUAL MEETING May 6, 2021 May 5, 2021
8-K Report 8-K - USPTO ORANGE BOOK Apr 6, 2021 Apr 6, 2021
SC 13G/A Report AMENDMENT TO SC 13G Mar 26, 2021
8-K Report 8-K - 4Q2020 Mar 11, 2021 Mar 11, 2021
10-K Report | Data 10-K Mar 11, 2021 Dec 31, 2020
SC 13G Report SCHEDULE FILED TO REPORT ACQUISITION OF BENEFICIAL OWNERSHIP Jan 20, 2021
8-K Report 8-K Jan 14, 2021 Jan 13, 2021
8-K Report 8-K Jan 13, 2021 Jan 13, 2021
8-K Report 8-K Dec 23, 2020 Dec 22, 2020
10-Q Report | Data 10-Q Nov 10, 2020 Sep 30, 2020
8-K Report 8-K Nov 10, 2020 Nov 10, 2020
8-K Report 8-K Oct 26, 2020 Oct 26, 2020
8-K Report 8-K Sep 2, 2020 Aug 27, 2020
8-K Report 8-K Aug 25, 2020 Aug 25, 2020
10-Q Report | Data 10-Q Aug 6, 2020 Jun 30, 2020
8-K Report 8-K Aug 6, 2020 Aug 6, 2020
8-K Report 8-K Jul 15, 2020 Jul 15, 2020
8-K Report 8-K Jul 8, 2020 Jul 8, 2020
8-K Report 8-K Jun 19, 2020 Jun 19, 2020
8-K Report 8-K May 28, 2020 May 27, 2020
8-K Report 8-K May 20, 2020 May 20, 2020
8-K Report 8-K May 12, 2020 May 12, 2020
10-Q Report | Data 10-Q May 12, 2020 Mar 31, 2020
10-K Report | Data 10-K Mar 12, 2020 Dec 31, 2019
8-K Report 8-K Mar 12, 2020 Mar 12, 2020
SC 13G Report SC 13G Feb 11, 2020
8-K Report 8-K Jan 27, 2020 Jan 27, 2020
8-K Report 8-K Jan 23, 2020 Jan 21, 2020
8-K Report 8-K Jan 21, 2020 Jan 21, 2020
8-K Report 8-K Dec 20, 2019 Dec 20, 2019
8-K Report 8-K Dec 2, 2019 Nov 29, 2019
8-K Report 8-K-NASDAQ EXTENSION Nov 13, 2019 Nov 12, 2019
10-Q Report | Data 10-Q Nov 7, 2019 Sep 30, 2019
8-K Report 8-K Nov 7, 2019 Nov 7, 2019
8-K Report 8-K Sep 17, 2019 Sep 17, 2019
10-Q Report | Data 10-Q Aug 8, 2019 Jun 30, 2019
8-K Report 8-K Aug 8, 2019 Aug 8, 2019
8-K Report 8-K Jun 27, 2019 Jun 26, 2019
8-K Report 8-K Jun 19, 2019 Jun 17, 2019
8-K Report 8-K May 17, 2019 May 15, 2019
10-Q Report | Data 10-Q1-2019 May 8, 2019 Mar 31, 2019
8-K Report 8-K - Q1 EARNINGS May 8, 2019 May 8, 2019
8-K Report 8-K May 3, 2019 May 2, 2019
8-K Report 8-K Apr 2, 2019 Apr 2, 2019
8-K Report 8-K Mar 14, 2019 Mar 14, 2019
10-K Report | Data 10-K Mar 6, 2019 Dec 31, 2018
8-K Report 8-K Mar 6, 2019 Mar 6, 2019
8-K Report 8-K Mar 4, 2019 Mar 4, 2019
SC 13G/A Report SC 13G/A Jan 17, 2019
8-K Report 8-K Jan 7, 2019 Jan 5, 2019
10-Q Report | Data 10-Q Nov 13, 2018 Sep 30, 2018
8-K Report 8-K Nov 13, 2018 Nov 13, 2018
8-K Report 8-K Aug 16, 2018 Aug 16, 2018
10-Q Report | Data 10-Q Aug 9, 2018 Jun 30, 2018
8-K Report 8-K - Q2 Aug 9, 2018 Aug 9, 2018
8-K Report 8-K Jun 4, 2018 Jun 4, 2018
10-Q Report | Data 10-Q1 May 14, 2018 Mar 31, 2018
8-K Report 8-K - Q1 EARNINGS May 14, 2018 May 14, 2018
8-K Report 8-K - MEXICAN PATENT May 10, 2018 May 9, 2018
SC 13G Report SC 13G May 8, 2018
8-K Report 8-K - EUROPEAN PATENT Apr 30, 2018 Apr 30, 2018
8-K Report 8-K - ANNUAL MEETING RESULTS 2018 Apr 27, 2018 Apr 26, 2018
8-K/A Report 8-K/A 6APR2018 Apr 6, 2018 Mar 29, 2018
8-K Report 8-K Apr 4, 2018 Mar 29, 2018
8-K Report 8-K - MALLINCKRODT Mar 26, 2018 Mar 21, 2018
8-K Report 8-K Mar 23, 2018 Mar 22, 2018
10-K Report | Data 10-K-2017 Mar 7, 2018 Dec 31, 2017
8-K Report 8-K Mar 7, 2018 Mar 7, 2018
8-K Report 8-K Mar 5, 2018 Mar 5, 2018
8-K Report 8-K - PR - FDA Feb 15, 2018 Feb 15, 2018
SC 13G/A Report Jan 16, 2018
8-K Report 8-K Q3 EARNINGS RELEASE Nov 14, 2017 Nov 14, 2017
10-Q Report | Data 10-Q3 Nov 14, 2017 Sep 30, 2017
8-K Report 8-K - COMMERCIAL MANUFACTURING Nov 9, 2017 Nov 7, 2017
8-K Report 8-K - POSITIVE RESULTS Oct 23, 2017 Oct 23, 2017
8-K Report 8-K Sep 12, 2017 Sep 12, 2017
10-Q Report | Data 10-Q Aug 14, 2017 Jun 30, 2017
8-K Report 8-K Aug 14, 2017 Aug 14, 2017
8-K Report 8-K-DOSING Aug 14, 2017 Aug 14, 2017
8-K Report 8-K May 15, 2017 May 15, 2017
10-Q Report | Data 10-Q May 15, 2017 Mar 31, 2017
8-K Report 8-K - DDW May 10, 2017 May 10, 2017
8-K Report 8-K May 4, 2017 May 3, 2017
8-K Report 8-K Apr 18, 2017 Apr 18, 2017
8-K Report 8-K - PK PROTOCOL Apr 4, 2017 Apr 4, 2017
8-K Report 8-K Mar 21, 2017 Mar 21, 2017
10-K Report | Data EVOK-10K-20161231 Mar 15, 2017 Dec 31, 2016
8-K Report 8-K Mar 15, 2017 Mar 15, 2017
8-K Report 8-K Mar 10, 2017 Mar 10, 2017
8-K Report 8-K Feb 16, 2017 Feb 15, 2017
8-K Report 8-K Feb 15, 2017 Feb 15, 2017
SC 13G/A Report SC 13G/A Feb 14, 2017
SC 13G/A Report SCHEDULE 13G/A FOR EVOKE PHARMA, INC. BY DOMAIN PARTNERS VII, L.P. Jan 9, 2017
8-K Report 8-K Jan 9, 2017 Jan 9, 2017
8-K Report 8-K Jan 4, 2017 Jan 4, 2017
8-K Report 8-K Dec 21, 2016 Dec 19, 2016
8-K Report 8-K Dec 16, 2016 Dec 15, 2016
8-K Report 8-K Dec 15, 2016 Dec 15, 2016
8-K Report 8-K Nov 9, 2016 Nov 9, 2016
10-Q Report | Data 10-Q Nov 9, 2016 Sep 30, 2016
8-K Report FORM 8-K Sep 7, 2016 Sep 7, 2016
8-K Report 8-K Aug 15, 2016 Aug 15, 2016
10-Q Report | Data 10-Q Aug 15, 2016 Jun 30, 2016
8-K Report 8-K Aug 8, 2016 Aug 4, 2016
SC 13G Report SC 13G Aug 5, 2016
8-K Report 8-K Aug 1, 2016 Jul 29, 2016
SC 13G Report EVOKE PHARMA, INC. Jul 29, 2016
SC 13G Report SC 13G Jul 27, 2016
SC 13G Report SC 13G Jul 26, 2016
SC 13G/A Report NONE Jul 22, 2016
8-K Report FORM 8-K Jul 20, 2016 Jul 19, 2016
8-K Report 8-K Jul 18, 2016 Jul 18, 2016
8-K Report 8-K - INVENTIVE Jul 7, 2016 Jul 6, 2016
SC 13G Report NONE Jun 3, 2016
8-K Report 8-K Jun 2, 2016 Jun 1, 2016
8-K Report 8-K May 19, 2016 May 16, 2016
8-K Report | Data 8-K May 11, 2016 May 11, 2016
10-Q Report | Data 10-Q May 11, 2016 Mar 31, 2016
8-K Report 8-K May 3, 2016 May 3, 2016
8-K Report 8-K Apr 28, 2016 Apr 27, 2016
8-K Report 8-K Apr 25, 2016 Apr 25, 2016
8-K Report 8-K Apr 15, 2016 Apr 15, 2016
8-K Report 8-K Mar 10, 2016 Mar 10, 2016
10-K Report | Data 10-K Mar 10, 2016 Dec 31, 2015
8-K Report 8-K Mar 1, 2016 Feb 29, 2016
SC 13G/A Report AMENDMENT 1 TO SCHEDULE 13G FOR EVOKE PHARMA BY DOMAIN PARTNERS VII, L.P. Jan 19, 2016
8-K Report 8-K Nov 12, 2015 Nov 12, 2015
10-Q Report | Data 10-Q Nov 12, 2015 Sep 30, 2015
8-K Report 8-K Oct 7, 2015 Oct 6, 2015
8-K Report 8-K Sep 28, 2015 Sep 28, 2015
8-K Report 8-K Sep 16, 2015 Sep 15, 2015
8-K Report 8-K Aug 18, 2015 Aug 18, 2015
8-K Report 8-K Aug 13, 2015 Aug 13, 2015
10-Q Report | Data 10-Q Aug 13, 2015 Jun 30, 2015
8-K Report 8-K May 14, 2015 May 14, 2015
10-Q Report | Data 10-Q May 14, 2015 Mar 31, 2015
8-K Report 8-K Apr 23, 2015 Apr 22, 2015
8-K Report 8-K Apr 14, 2015 Apr 14, 2015
8-K Report 8-K Apr 9, 2015 Apr 9, 2015
8-K Report 8-K Mar 11, 2015 Mar 11, 2015
8-K Report 8-K Mar 4, 2015 Mar 4, 2015
10-K Report | Data 10-K Mar 4, 2015 Dec 31, 2014
SC 13G Report 13G SUBMISSION Feb 12, 2015
SC 13G Report SC 13G SUBMISSION FILE Feb 11, 2015
8-K Report 8-K Feb 2, 2015 Feb 2, 2015
8-K Report 8-K Jan 22, 2015 Jan 21, 2015
8-K Report 8-K Jan 6, 2015 Dec 31, 2014
8-K Report FORM 8-K Dec 2, 2014 Nov 25, 2014
8-K Report FORM 8-K Dec 2, 2014 Dec 2, 2014
10-Q Report | Data 10-Q Nov 13, 2014 Sep 30, 2014
10-Q Report | Data 10-Q Aug 13, 2014 Jun 30, 2014
8-K Report FORM 8-K May 28, 2014 May 23, 2014
8-K Report FORM 8-K May 21, 2014 May 21, 2014
10-Q Report | Data FORM 10-Q May 13, 2014 Mar 31, 2014
8-K Report FORM 8-K May 13, 2014 May 13, 2014
10-K Report | Data 10-K Mar 25, 2014 Dec 31, 2013
8-K Report FORM 8-K Mar 25, 2014 Mar 25, 2014
SC 13G Report SC 13G Feb 13, 2014
8-K Report FORM 8-K Feb 7, 2014 Feb 6, 2014
SC 13G Report SCHEDULE 13G FOR EVOKE PHARMA, INC. BY DOMAIN PARTNERS VII, L.P. Feb 6, 2014
8-K Report FORM 8-K Jan 31, 2014 Jan 29, 2014
8-K Report FORM 8-K Dec 2, 2013 Dec 1, 2013
8-K Report FORM 8-K Dec 2, 2013 Nov 25, 2013
10-Q Report | Data FORM 10-Q Nov 13, 2013 Sep 30, 2013
8-K Report FORM 8-K Nov 13, 2013 Nov 13, 2013
8-K Report FORM 8-K Oct 8, 2013 Oct 8, 2013
8-K Report 8-K Sep 30, 2013 Sep 30, 2013